Symbols / TNDM Stock $16.23 -7.84% Tandem Diabetes Care, Inc.

Healthcare • Medical Devices • United States • NGM
TNDM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. John F. Sheridan
Exch · Country NGM · United States
Market Cap 1.11B
Enterprise Value 1.28B
Income -94.55M
Sales 1.03B
FCF (ttm) -20.26M
Book/sh 2.27
Cash/sh 8.32
Employees 2,500
Insider 10d —
IPO Nov 14, 2013
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 276.30
PEG —
P/S 1.08
P/B 7.14
P/C —
EV/EBITDA -29.55
EV/Sales 1.24
Quick Ratio 2.87
Current Ratio 3.58
Debt/Eq 554.92
LT Debt/Eq —
EPS (ttm) -1.37
EPS next Y 0.06
EPS Growth —
Revenue Growth 5.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-07
ROA -3.68%
ROE -65.73%
ROIC —
Gross Margin 54.93%
Oper. Margin -7.05%
Profit Margin -9.20%
Shs Outstand 68.53M
Shs Float 62.92M
Insider Own 0.97%
Instit Own 117.89%
Short Float 23.16%
Short Ratio 3.91
Short Interest 11.79M
52W High 29.65
vs 52W High -45.26%
52W Low 9.98
vs 52W Low 62.63%
Beta 1.57
Impl. Vol. 1.56%
Rel Volume 1.23
Avg Volume 2.31M
Volume 2.85M
Target (mean) $29.20
Tgt Median $27.50
Tgt Low $17.00
Tgt High $50.00
# Analysts 20
Recom Buy
Prev Close $17.61
Price $16.23
Change -7.84%
About

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$29.20
Mean price target
2. Current target
$16.23
Latest analyst target
3. DCF / Fair value
$-5.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.23
Low
$17.00
High
$50.00
Mean
$29.20

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-06-01 up Wells Fargo Equal-Weight → Overweight $27
2026-05-28 main Citigroup Neutral → Neutral $17
2026-05-18 main B of A Securities Neutral → Neutral $25
2026-05-12 init Benchmark — → Hold —
2026-05-11 reit Truist Securities Buy → Buy $31
2026-05-11 main Barclays Overweight → Overweight $55
2026-04-20 main TD Cowen Buy → Buy $28
2026-04-09 main Goldman Sachs Neutral → Neutral $25
2026-03-19 up Truist Securities Hold → Buy $35
2026-03-17 up Piper Sandler Neutral → Overweight $33
2026-03-02 main Morgan Stanley Equal-Weight → Equal-Weight $25
2026-02-23 up Lake Street Hold → Buy $50
2026-02-23 reit Truist Securities Hold → Hold $27
2026-02-20 main Mizuho Neutral → Neutral $22
2026-02-20 main UBS Neutral → Neutral $22
2026-02-20 main Stifel Hold → Hold $22
2026-02-20 up B of A Securities Underperform → Neutral $30
2026-02-20 main Piper Sandler Neutral → Neutral $21
2026-02-04 main Stifel Hold → Hold $20
2026-01-09 main Bernstein Market Perform → Market Perform $25
News
RSS: Latest TNDM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-02 GASSER ELIZABETH ANNE Officer — 7,160 $0.00 $0
2026-05-21 ROBERTSON REBECCA B Director — 8,759 — —
2026-05-21 HOWELL-KOREN PEYTON R. Director — 8,759 — —
2026-05-21 ALLEN DICK P Retired — 8,759 — —
2026-05-21 TWOMEY CHRISTOPHER J Director — 8,759 — —
2026-05-21 CHA MYOUNGIL Director — 8,759 — —
2026-05-21 MALAGUEIRA JOAO PAULO FALCAO Director — 8,759 — —
2026-05-21 SODHI RAJWANT Director — 8,759 — —
2026-05-21 MCGRODDY-GOETZ KATHLEEN Director — 8,759 — —
2026-05-15 SHERIDAN JOHN F Chief Executive Officer — 51,189 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,014.74
+7.93%
940.20
+25.74%
747.72
-6.68%
801.22
Operating Revenue
1,014.74
+7.93%
940.20
+25.74%
747.72
-6.68%
801.22
Cost Of Revenue
468.72
+4.02%
450.63
+18.58%
380.03
-2.11%
388.23
Reconciled Cost Of Revenue
468.72
+4.02%
450.63
+18.58%
380.03
-2.11%
388.23
Gross Profit
546.01
+11.53%
489.57
+33.15%
367.69
-10.97%
412.99
Operating Expense
713.32
+21.17%
588.70
-2.03%
600.92
+18.80%
505.83
Research And Development
268.33
+34.92%
198.88
-19.94%
248.42
+46.00%
170.15
Selling General And Administration
444.99
+14.15%
389.82
+10.59%
352.50
+5.01%
335.68
Total Expenses
1,182.04
+13.73%
1,039.33
+5.95%
980.95
+9.72%
894.07
Operating Income
-167.31
-68.78%
-99.13
+57.50%
-233.23
-151.20%
-92.85
Total Operating Income As Reported
-187.26
-88.91%
-99.13
+57.50%
-233.23
-151.20%
-92.85
EBITDA
-176.56
-153.12%
-69.75
+64.49%
-196.46
-164.74%
-74.21
Normalized EBITDA
-156.61
-128.67%
-68.49
+65.14%
-196.46
-164.22%
-74.36
Reconciled Depreciation
17.67
+6.38%
16.61
+5.68%
15.71
+9.67%
14.33
EBIT
-194.22
-124.90%
-86.36
+59.30%
-212.18
-139.64%
-88.54
Total Unusual Items
-19.95
-1473.42%
-1.27
0.00
-100.00%
0.15
Total Unusual Items Excluding Goodwill
-19.95
-1473.42%
-1.27
0.00
-100.00%
0.15
Special Income Charges
-19.95
-1473.42%
-1.27
0.00
0.00
Other Special Charges
19.95
+1473.42%
1.27
-98.39%
78.75
+153.71%
31.04
Net Income
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Pretax Income
-200.27
-117.99%
-91.87
+58.29%
-220.25
-137.21%
-92.85
Net Non Operating Interest Income Expense
1.18
-88.85%
10.58
-18.48%
12.98
+8636.84%
-0.15
Interest Expense Non Operating
6.05
+9.77%
5.51
-31.81%
8.08
+87.32%
4.31
Net Interest Income
1.18
-88.85%
10.58
-18.48%
12.98
+8636.84%
-0.15
Interest Expense
6.05
+9.77%
5.51
-31.81%
8.08
+87.32%
4.31
Interest Income Non Operating
9.09
-49.50%
17.99
-21.28%
22.86
+277.38%
6.06
Interest Income
9.09
-49.50%
17.99
-21.28%
22.86
+277.38%
6.06
Other Income Expense
-34.15
-928.15%
-3.32
+95.78%
-78.75
-53671.43%
0.15
Gain On Sale Of Security
—
—
—
0.15
Tax Provision
4.44
+6.81%
4.16
+76.28%
2.36
+35.30%
1.74
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-4.19
-1473.42%
-0.27
0.00
-100.00%
0.03
Net Income Including Noncontrolling Interests
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Net Income From Continuing Operation Net Minority Interest
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Net Income From Continuing And Discontinued Operation
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Net Income Continuous Operations
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Normalized Income
-188.95
-98.84%
-95.02
+57.31%
-222.61
-135.04%
-94.71
Net Income Common Stockholders
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Diluted EPS
-3.04
-106.80%
-1.47
+57.14%
-3.43
-133.33%
-1.47
Basic EPS
-3.04
-106.80%
-1.47
+57.14%
-3.43
-133.33%
-1.47
Basic Average Shares
67.28
+2.80%
65.45
+0.74%
64.97
+1.28%
64.15
Diluted Average Shares
67.28
+2.80%
65.45
+0.74%
64.97
+1.28%
64.15
Diluted NI Availto Com Stockholders
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Earnings From Equity Interest
-14.19
-591.38%
-2.05
0.00
0.00
Total Other Finance Cost
1.86
-2.41%
1.91
+5.71%
1.80
-4.91%
1.90
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
881.11
-8.94%
967.66
+1.57%
952.66
-9.51%
1,052.79
Current Assets
618.14
-14.68%
724.49
-3.14%
747.99
-12.00%
849.98
Cash Cash Equivalents And Short Term Investments
292.67
-33.23%
438.33
-6.32%
467.91
-24.15%
616.90
Cash And Cash Equivalents
90.63
+30.91%
69.23
+17.61%
58.87
-65.88%
172.52
Cash Equivalents
—
—
—
—
Cash Financial
—
—
—
—
Other Short Term Investments
202.03
-45.26%
369.10
-9.77%
409.04
-7.95%
444.38
Receivables
165.49
+44.43%
114.58
+8.55%
105.56
-7.99%
114.72
Accounts Receivable
165.49
+44.43%
114.58
+8.55%
105.56
-7.99%
114.72
Gross Accounts Receivable
173.88
+42.72%
121.84
+10.31%
110.45
-7.22%
119.04
Allowance For Doubtful Accounts Receivable
-8.39
-15.75%
-7.25
-48.04%
-4.90
-13.20%
-4.33
Inventory
128.77
-13.93%
149.61
-5.27%
157.94
+42.14%
111.12
Raw Materials
31.77
-2.55%
32.60
-23.80%
42.78
+9.12%
39.21
Work In Process
23.80
-28.98%
33.52
-23.87%
44.03
+137.07%
18.57
Finished Goods
73.19
-12.34%
83.49
+17.38%
71.13
+33.35%
53.34
Prepaid Assets
—
—
—
—
Other Current Assets
31.22
+42.12%
21.96
+32.44%
16.59
+129.04%
7.24
Total Non Current Assets
262.97
+8.14%
243.17
+18.81%
204.67
+0.92%
202.81
Net PPE
179.75
+9.97%
163.46
-0.53%
164.33
-8.29%
179.18
Gross PPE
252.80
+11.72%
226.28
+4.22%
217.13
-7.74%
235.35
Accumulated Depreciation
-73.05
-16.27%
-62.83
-19.01%
-52.79
+6.02%
-56.17
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
17.23
-20.33%
21.62
-2.52%
22.18
-15.02%
26.10
Other Properties
99.27
+20.70%
82.25
+18.19%
69.59
+10.82%
62.80
Leases
136.30
+11.34%
122.41
-2.35%
125.36
-14.41%
146.45
Goodwill And Other Intangible Assets
11.72
+1167.03%
0.93
-66.68%
2.78
-40.00%
4.63
Other Intangible Assets
11.72
+1167.03%
0.93
-66.68%
2.78
-40.00%
4.63
Investments And Advances
60.35
-19.04%
74.55
0.00
—
Long Term Equity Investment
60.35
-19.04%
74.55
0.00
—
Other Non Current Assets
11.15
+162.82%
4.24
-88.71%
37.56
+97.64%
19.00
Total Liabilities Net Minority Interest
725.94
+3.03%
704.56
+10.26%
639.03
+4.27%
612.84
Current Liabilities
242.72
-1.75%
247.05
+26.52%
195.26
+18.13%
165.29
Payables And Accrued Expenses
68.08
+8.23%
62.90
+0.94%
62.31
-4.61%
65.33
Payables
47.07
+5.22%
44.73
-9.79%
49.59
-11.02%
55.73
Accounts Payable
47.07
+5.22%
44.73
-9.79%
49.59
-11.02%
55.73
Current Accrued Expenses
21.01
+15.64%
18.17
+42.78%
12.73
+32.63%
9.60
Pensionand Other Post Retirement Benefit Plans Current
70.41
+9.79%
64.13
+47.66%
43.43
+12.27%
38.68
Current Debt And Capital Lease Obligation
19.47
-66.93%
58.88
+245.12%
17.06
+30.02%
13.12
Current Debt
—
40.67
—
—
Other Current Borrowings
—
40.67
—
—
Current Capital Lease Obligation
19.47
+6.94%
18.21
+6.73%
17.06
+30.02%
13.12
Current Deferred Liabilities
9.53
-19.47%
11.83
-73.11%
43.99
+133.55%
18.84
Current Deferred Revenue
9.53
-19.47%
11.83
-73.11%
43.99
+133.55%
18.84
Other Current Liabilities
75.24
+52.57%
49.31
+73.26%
28.46
-2.94%
29.32
Total Non Current Liabilities Net Minority Interest
483.22
+5.62%
457.51
+3.10%
443.77
-0.84%
447.55
Long Term Debt And Capital Lease Obligation
425.00
+2.49%
414.69
+4.03%
398.61
-2.00%
406.76
Long Term Debt
310.04
+0.57%
308.27
+8.15%
285.04
+0.64%
283.23
Long Term Capital Lease Obligation
114.97
+8.03%
106.42
-6.30%
113.57
-8.06%
123.52
Non Current Deferred Liabilities
8.47
-18.95%
10.46
-21.57%
13.33
-21.00%
16.87
Non Current Deferred Revenue
8.47
-18.95%
10.46
-21.57%
13.33
-21.00%
16.87
Other Non Current Liabilities
49.74
+53.67%
32.37
+1.69%
31.83
+33.08%
23.92
Stockholders Equity
155.17
-41.02%
263.10
-16.11%
313.63
-28.71%
439.95
Common Stock Equity
155.17
-41.02%
263.10
-16.11%
313.63
-28.71%
439.95
Capital Stock
0.07
+3.03%
0.07
+0.00%
0.07
+1.54%
0.07
Common Stock
0.07
+3.03%
0.07
+0.00%
0.07
+1.54%
0.07
Share Issued
68.29
+3.06%
66.26
+1.09%
65.55
+1.61%
64.51
Ordinary Shares Number
68.29
+3.06%
66.26
+1.09%
65.55
+1.61%
64.51
Additional Paid In Capital
1,402.04
+6.80%
1,312.80
+3.86%
1,264.00
+7.95%
1,170.89
Retained Earnings
-1,252.54
-19.54%
-1,047.83
-10.09%
-951.80
-30.53%
-729.19
Gains Losses Not Affecting Retained Earnings
5.59
+387.26%
-1.95
-242.22%
1.37
+175.34%
-1.82
Other Equity Adjustments
5.59
+387.26%
-1.95
-242.22%
1.37
+175.34%
-1.82
Total Equity Gross Minority Interest
155.17
-41.02%
263.10
-16.11%
313.63
-28.71%
439.95
Total Capitalization
465.21
-18.58%
571.36
-4.56%
598.67
-17.22%
723.18
Working Capital
375.42
-21.37%
477.44
-13.62%
552.73
-19.27%
684.69
Invested Capital
465.21
-23.99%
612.03
+2.23%
598.67
-17.22%
723.18
Total Debt
444.48
-6.14%
473.56
+13.93%
415.67
-1.00%
419.88
Net Debt
219.40
-21.56%
279.70
+23.67%
226.17
+104.28%
110.72
Capital Lease Obligations
134.44
+7.87%
124.63
-4.60%
130.63
-4.40%
136.65
Net Tangible Assets
143.45
-45.28%
262.17
-15.66%
310.86
-28.59%
435.32
Tangible Book Value
143.45
-45.28%
262.17
-15.66%
310.86
-28.59%
435.32
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-9.72
-140.13%
24.23
+176.16%
-31.81
-163.04%
50.46
Cash Flow From Continuing Operating Activities
-9.72
-140.13%
24.23
+176.16%
-31.81
-163.04%
50.46
Net Income From Continuing Operations
-204.71
-113.18%
-96.03
+56.86%
-222.61
-135.33%
-94.59
Depreciation Amortization Depletion
17.67
+6.38%
16.61
+5.68%
15.71
+9.67%
14.33
Depreciation
15.10
+2.72%
14.70
+6.52%
13.80
+12.20%
12.30
Amortization Cash Flow
2.50
+31.58%
1.90
+0.00%
1.90
-5.00%
2.00
Depreciation And Amortization
17.67
+6.38%
16.61
+5.68%
15.71
+9.67%
14.33
Amortization Of Intangibles
2.50
+31.58%
1.90
+0.00%
1.90
-5.00%
2.00
Other Non Cash Items
88.14
+2778.41%
3.06
-96.80%
95.57
+130.34%
41.49
Stock Based Compensation
92.38
-8.88%
101.38
+15.11%
88.08
+3.72%
84.92
Provisionand Write Offof Assets
9.48
-5.02%
9.98
+80.13%
5.54
+15.85%
4.78
Asset Impairment Charge
—
—
—
7.57
Deferred Tax
—
—
—
0.00
Deferred Income Tax
—
—
—
0.00
Operating Gains Losses
14.19
+327.40%
3.32
—
-0.15
Gain Loss On Investment Securities
—
—
—
-0.15
Change In Working Capital
-23.04
-95.56%
-11.78
+33.38%
-17.68
-280.40%
-4.65
Change In Receivables
-56.81
-173.20%
-20.80
-586.21%
4.28
+154.62%
-7.83
Changes In Account Receivables
-56.81
-173.20%
-20.80
-586.21%
4.28
+154.62%
-7.83
Change In Inventory
24.82
+327.13%
5.81
+112.62%
-46.05
-8.48%
-42.45
Change In Prepaid Assets
-9.09
-63.31%
-5.57
+39.11%
-9.14
-15656.90%
-0.06
Change In Payables And Accrued Expense
1.56
-50.51%
3.16
+235.71%
-2.33
-109.68%
24.03
Change In Accrued Expense
-0.66
-111.96%
5.55
+118.76%
2.54
+650.33%
-0.46
Change In Payable
2.23
+193.10%
-2.39
+50.82%
-4.86
-119.86%
24.49
Change In Account Payable
2.23
+193.10%
-2.39
+50.82%
-4.86
-119.86%
24.49
Change In Other Working Capital
1.21
+108.70%
-13.88
-151.99%
26.69
+691.71%
-4.51
Change In Other Current Assets
-6.89
-871.33%
0.89
+128.02%
-3.19
-164.04%
-1.21
Change In Other Current Liabilities
22.16
+19.19%
18.59
+54.29%
12.05
-55.98%
27.38
Investing Cash Flow
72.88
+410.35%
-23.48
+72.61%
-85.74
-358.50%
33.17
Cash Flow From Continuing Investing Activities
72.88
+410.35%
-23.48
+72.61%
-85.74
-358.50%
33.17
Net PPE Purchase And Sale
-19.95
-3.73%
-19.23
+28.25%
-26.80
+21.39%
-34.10
Purchase Of PPE
-19.95
-3.73%
-19.23
+28.25%
-26.80
+21.39%
-34.10
Capital Expenditure
-98.54
-412.38%
-19.23
+80.03%
-96.30
-182.43%
-34.10
Net Investment Purchase And Sale
171.41
+4132.27%
-4.25
-140.26%
10.56
-88.64%
92.98
Purchase Of Investment
-85.66
+72.43%
-310.71
+41.99%
-535.66
-12.41%
-476.51
Sale Of Investment
257.07
-16.12%
306.46
-43.89%
546.22
-4.09%
569.49
Net Business Purchase And Sale
—
0.00
+100.00%
-69.50
-170.20%
-25.72
Purchase Of Business
—
0.00
+100.00%
-69.50
-170.20%
-25.72
Net Intangibles Purchase And Sale
-78.59
0.00
+100.00%
-69.50
-684.82%
-8.86
Purchase Of Intangibles
-78.59
0.00
+100.00%
-69.50
-684.82%
-8.86
Financing Cash Flow
-43.37
-618.31%
8.37
+103.43%
4.11
-75.63%
16.88
Cash Flow From Continuing Financing Activities
-43.37
-618.31%
8.37
+103.43%
4.11
-75.63%
16.88
Net Issuance Payments Of Debt
-40.76
-167.12%
60.73
0.00
0.00
Issuance Of Debt
0.00
-100.00%
306.85
0.00
0.00
Repayment Of Debt
-40.76
+83.44%
-246.12
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
306.85
0.00
0.00
Long Term Debt Payments
-40.76
+83.44%
-246.12
0.00
0.00
Net Long Term Debt Issuance
-40.76
-167.12%
60.73
0.00
0.00
Net Common Stock Issuance
0.00
+100.00%
-30.00
0.00
0.00
Proceeds From Stock Option Exercised
-2.61
+61.26%
-6.73
-260.85%
4.18
-76.05%
17.47
Net Other Financing Charges
—
-15.63
-21914.08%
-0.07
+88.01%
-0.59
Changes In Cash
19.79
+117.21%
9.11
+108.03%
-113.44
-212.86%
100.51
Effect Of Exchange Rate Changes
1.61
+28.34%
1.26
+692.45%
-0.21
-125.63%
0.83
Beginning Cash Position
69.23
+17.61%
58.87
-65.88%
172.52
+142.36%
71.18
End Cash Position
90.63
+30.91%
69.23
+17.61%
58.87
-65.88%
172.52
Free Cash Flow
-108.26
-2267.74%
4.99
+103.90%
-128.11
-882.73%
16.37
Interest Paid Supplemental Data
5.05
+64.14%
3.08
-59.34%
7.57
+75.40%
4.31
Income Tax Paid Supplemental Data
5.06
+63.20%
3.10
+61.10%
1.92
+367.88%
0.41
Amortization Of Securities
-3.83
-64.93%
-2.32
-164.71%
3.59
-14.33%
4.19
Earnings Losses From Equity Investments
14.19
+591.38%
2.05
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category